Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial Meeting Abstract
| Authors: | Haugen, B.; French, J. D.; Worden, F.; Konda, B.; Sherman, E. J.; Dadu, R.; Gianoukakis, A. G.; McCue, S.; Foster, N.; Bowles, D. W.; Wirth, L. J. |
| Abstract Title: | Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S1086 |
| End Page: | S1087 |
| Language: | English |
| ACCESSION: | WOS:000573469102501 |
| DOI: | 10.1016/j.annonc.2020.08.1405 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1917P -- Source: Wos |
